• Why CSL, Elders, Evolution, & Xero shares are dropping lower

    The S&P/ASX 200 Index (ASX: XJO) has returned from the long weekend in fine form. In late morning trade the benchmark index is up over 2.5% to 6,150.9 points.

    Four shares that have failed to follow the market higher today are listed below. Here’s why they are dropping lower:

    The CSL Limited (ASX: CSL) share price is down 2.5% to $277.77. This appears to be down to concerns that the company’s plasma collection network has been disrupted by the pandemic. This could have a knock-on effect on its FY 2021 performance. These concerns have offset an announcement that reveals that CSL has agreed to acquire biotech company Vitaeris this morning.

    The Elders Ltd (ASX: ELD) share price has fallen over 3% to $9.22. This decline could be down to profit taking after a strong share price gain year to date. Prior to today, the agribusiness company’s shares were up over 47% since the start of the year. Investors have been buying agriculture shares due to improving trading conditions and their defensive qualities.

    The Evolution Mining Ltd (ASX: EVN) share price is down 3% to $5.43. The catalyst for this decline was a sharp pullback in the gold price on Friday night. And although the precious metal rebounded last night, it wasn’t enough to stop the gold miners from being sold off today. Especially with investors switching to risk on assets en masse today. The S&P/ASX All Ordinaries Gold index is down 1.75% on Monday.

    The Xero Limited (ASX: XRO) share price has fallen almost 3% to $85.05. Investors may be taking profit off the table after some strong gains by the business and accounting platform provider’s shares in recent weeks. In fact, last week the Xero share price climbed to a record high of $91.49. When its shares hit that level, they were up 15% year to date.

    Need a lift after these declines? Then you won’t want to miss the recommendations below…

    5 ASX stocks under $5

    One trick to potentially generating life-changing wealth from the stock market is to buy early-stage growth companies when their share prices still look dirt cheap.

    Motley Fool’s resident tech stock expert Dr. Anirban Mahanti has identified 5 stocks he thinks are screaming buys. And you can buy them now for less than $5 a share!

    *  Extreme Opportunities returns as of June 5th 2020

    More reading

    James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. and Xero. The Motley Fool Australia has recommended Elders Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Why CSL, Elders, Evolution, & Xero shares are dropping lower appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2YdJctz

  • 2 ASX 200 biotech shares to consider buying today

    asx healthcare shares

    There are a couple of ASX 200 biotech shares that could be in the buy zone right now. The S&P/ASX 200 Index (ASX: XJO) is down -10.25% this year but many Aussie healthcare companies have surged in value.

    This is partly due to the nature of the coronavirus pandemic. Many healthcare services are in high demand even as the economy falls on hard times.

    While not all Aussie biotech companies are created equal, here are a couple of my top picks to buy today.

    2 ASX 200 biotech shares to buy today

    I like the look of CSL Limited (ASX: CSL) right now. CSL is one of the largest companies by market capitalisation on the ASX and weighs in at $129.55 billion.

    The ASX 200 biotech share doesn’t always look like good value. However, CSL shares have dropped below the $300 per share mark and are trading at $276.45 at the time of writing.

    We’ve seen some strong investor support around the $270-280 per share mark in recent months. That could mean now is a good chance to buy CSL at a 16.75% discount to its all-time high.

    It’s not just the Aussie biotech giant that is in the buy zone. I also like the look of Polynovo Ltd (ASX: PNV) shares right now.

    Polynovo designs develops and manufactures dermal regeneration solutions using its patented NovoSorb BTM biodegradable polymer technology.

    In plain English, the ASX 200 biotech share develops solutions for burns, skin grafts and similar medical issues.

    The Polynovo share price crashed hard in the recent bear market. In fact, shares in the company fell 56.29% from 25 February to 23 March. 

    However, Polynovo’s value has surged higher in recent months. The ASX 200 biotech share boasts a market capitalisation of $1.75 billion and has climbed 94.70% since that March 23 bottom.

    Foolish takeaway

    I think for buy and hold investors, both CSL and Polynovo could be good value buys.

    Both ASX 200 biotech shares have a track record of success and a solid growth outlook.

    I would say CSL is more of a tactical buy for $285.33 per share. In contrast, the Polynovo share price has already rebounded but I think it’s a potential ASX 50 share in the coming decade.

    For more ASX shares to buy for a good price, check out these cheap picks today!

    NEW! 5 Cheap Stocks With Massive Upside Potential

    Our experts at The Motley Fool have just released a FREE report detailing 5 shares you can buy now to take advantage of the much cheaper share prices on offer.

    One is a diversified conglomerate trading over 30% off it’s all-time high, all while offering a fully franked dividend yield of over 3%…

    Another is a former stock market darling that is one of Australia’s most popular and iconic businesses. Trading at a significant discount to its 52-week high, not only does this stock offer massive upside potential, but it also trades on an attractive fully franked dividend yield of almost 4%.

    Plus, this free report highlights 3 more cheap bets that could position you to profit in 2020 and beyond.

    Simply click here to scoop up your FREE copy and discover the names of all 5 cheap shares.

    But you will have to hurry because the cheap share prices on offer today might not last for long.

    As of 2/6/2020

    More reading

    Ken Hall has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post 2 ASX 200 biotech shares to consider buying today appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2XKLi5e

  • 3 ASX 200 shares to watch this week

    watch, watch list, observe, keep an eye on

    It was a strong week for ASX shares as the S&P/ASX 200 Index (ASX: XJO) surged 4.22% higher last week to close just shy of 6,000 points.

    The benchmark Aussie index finished the week at 5,998.70 points and was led higher by many Aussie blue chips including the banks.

    Last week I was watching Bendigo and Adelaide Bank Ltd (ASX: BEN)Flight Centre Travel Group Ltd (ASX: FLT) and St Barbara Ltd (ASX: SBM).

    The Bendigo share price was one of last week’s biggest moving as it rocketed 19.02% higher including a 4.72% gain on Friday. Flight Centre shares also surged, gaining 17.66%, while St Barbara shares were sold-off in the bullish ASX 200 share market and closed the week down 3.85%.

    After a big week for last week’s top picks, here are 3 shares I’ll be watching in the week ahead.

    3 ASX 200 shares to watch this week

    I always like to watch some of the biggest movers from the previous week. That means Stockland Corporation Ltd (ASX: SGP) is in my sights.

    The Stockland share price rocketed 10.92% last week and is up another 4.04% at the time of writing. The Aussie real estate investment trust (REIT) seems to be climbing thanks to investor optimism.

    Stockland has interests in retail, office and residential real estate. There are a lot of factors at play in all of those areas right now. I think this ASX 200 REIT could be set to recover further if the re-opening of the economy continues at a cracking pace.

    Another ASX 200 share I’ve got my eye on is SkyCity Entertainment Group Limited (ASX: SKC). SkyCity operates a number of hotels and wagering businesses that are starting to see eased restrictions.

    That could be good news for SkyCity earnings in FY20 and FY21. The entertainment share is up a whopping 8.96% in morning trade so far and will be well worth watching this week.

    I also think it’s hard to ignore the ASX banks right now. The Westpac Banking Corp (ASX: WBC) share price is one I’m watching this week.

    The big four bank’s shares have some strong momentum after rocketing 9.12% higher last week. Westpac shares have shot out of the gates this morning to be up more than 5% at the time of writing.

    I’d expect investors to continue buying high-quality shares this week. Westpac shares are still down 22.45% for the year and could have further to go in 2020.

    Foolish takeaway

    These are just a few of the ASX 200 shares I’m watching at the moment. It’s important to focus on the long-term investment horizon rather than getting too caught up in daily or weekly moves.

    There might be tactical buying opportunities on offer from time to time. However, I believe a buy and hold strategy is still the ticket to long-term wealth.

    If you’re in the market for more income in 2020, check out this top dividend pick today!

    NEW: Expert names top dividend stock for 2020 (free report)

    When our resident dividend expert Edward Vesely has a stock tip, it can pay to listen. After all, he’s the investing genius that runs Motley Fool Dividend Investor, the newsletter service that has picked huge winners like Dicker Data (+92%), SDI Limited (+53%) and National Storage (+35%).*

    Edward has just named what he believes is the number one ASX dividend stock to buy for 2020.

    This fully franked “under the radar” company is currently trading more than 24% below its all-time high and paying a 6.7% grossed-up dividend.

    The name of this dividend dynamo and the full investment case is revealed in this brand new free report.

    But you will have to hurry — history has shown it can pay dividends to get in early to some of Edward’s stock picks, and this dividend stock is already on the move.

    See the top dividend stock for 2020

    More reading

    Motley Fool contributor Ken Hall has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Flight Centre Travel Group Limited and Sky City Entertainment Group Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post 3 ASX 200 shares to watch this week appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3f7Nw4v

  • Can the Wesfarmers share price continue to rise after its market update today?

    Man holding credit card in front of laptop for ebay purchase

    The share price of Wesfarmers Ltd (ASX: WES) will be on watch this morning after it provided the market with a retail trading update for its performance in 2H20 so far.

    The group revealed today that it has witnessed particularly strong demand from both its Bunnings and Officeworks stores.

    The Wesfarmers share price has bounced back strongly since late March. The group’s share price has risen from $31.02 on 23 March to close at $41.71 last Friday. That’s an impressive increase of 34.5%.

    Bunnings and Officeworks sales grow strongly

    Compared to sales in the first half of the year (1H20), sales for Bunnings have risen very strongly so far in the current half (2H20). Bunning’s sales have risen 19.2% since the beginning of the year. This compares to only 5.8% during 1H20.  For the FY2020 year-to-date, sales have also risen strongly for Bunnings. They were up by 11.3% compared to the prior corresponding period.

    As a result of the coronavirus crisis, Australians have continued to spend more on goods to assist them in working and learning in a home environment.

    The performance of Officeworks was also very strong. Sales were up by 27.8% for 2H20 to date, compared to only 11.5% in 1H20. FY2020 sales to date were also strongly up by 19.3% for Officeworks.

    I believe that the strong performance of both Bunnings and Officeworks has made a significant contribution to Wesfarmers’ recent strong share price growth.

    Pure online retailer Catch sees sales surge

    The star performer for Wesfarmers in recent months has been its pure online offering in Catch.

    Online sales for Catch have risen by a massive 68.7% in the half-year to date. This compares to only 21.4% in 1H20.

    There has been a recent surge in online sales due to the coronavirus. All of Wesfarmers’ retail businesses witnessed massive combined total online sales growth of 89% for the half-year to date.

    Wesfarmers’ online offerings have seen strong growth over the past few years.

    It is quite likely that consumer habits are changing permanently. Many Australians may continue to choose the online channel over bricks and mortar stores in the years ahead due to its convenience and price competitiveness.

    Where to now for the Wesfarmers share price?

    As already mentioned, the group’s share price growth since late March has been very strong. However, I believe that Wesfarmers will be challenged to keep growing at this pace in the months ahead. Wesfarmers itself acknowledged today that it is uncertain if this sales growth can continue for the rest of the year. As government lockdown measures continue to ease, shopping patterns are likely to continue to get back to normal sooner rather than later.

    For additional shares worth having a look at, take a look at the free Fool report below.

    NEW: Expert names top dividend stock for 2020 (free report)

    When our resident dividend expert Edward Vesely has a stock tip, it can pay to listen. After all, he’s the investing genius that runs Motley Fool Dividend Investor, the newsletter service that has picked huge winners like Dicker Data (+92%), SDI Limited (+53%) and National Storage (+35%).*

    Edward has just named what he believes is the number one ASX dividend stock to buy for 2020.

    This fully franked “under the radar” company is currently trading more than 24% below its all-time high and paying a 6.7% grossed-up dividend.

    The name of this dividend dynamo and the full investment case is revealed in this brand new free report.

    But you will have to hurry — history has shown it can pay dividends to get in early to some of Edward’s stock picks, and this dividend stock is already on the move.

    See the top dividend stock for 2020

    More reading

    Motley Fool contributor Phil Harpur has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of Wesfarmers Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Can the Wesfarmers share price continue to rise after its market update today? appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2A6tN6s

  • If you need to protect your portfolio, do this now

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    Young female investor holding cash

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    2020 has been a wild year for investors. The stock market soared to new highs, only to plunge in the wake of the coronavirus outbreak. After hitting bottom, markets have soared upward in a quick recovery, and at least a couple of stock benchmarks have reached new records once again.

    When the initial phase of the COVID-19 outbreak led to one of the fastest bear markets in history, the best advice investors could follow was not to make any rash decisions with their investments. That advice served those who followed it well, as the bounce has helped many investors recover much or even all of their losses. Staying pat was hard, though, if you felt blindsided by the coronavirus crisis and suddenly became aware that the risk level in your portfolio was too high.

    Fortunately, you now have your chance to reconsider your investing strategy calmly and objectively. If the bear market was a wake-up call that you had too much risk in your portfolio, then now that stocks have recovered most of their lost ground, you can adjust your asset allocation  without doing major damage to your long-term financial prospects.

    Letting it ride

    The 2010s were one of the most successful decades ever for stock market investors. The right strategy to follow was to get money into the market whenever you could, especially taking advantage of periodic dips to add to your positions. With very few extended downward moves in the market, it was easy to think that owning stocks didn’t really involve much risk.

    However, the big gains from the 2010s set up some investors for a surprisingly painful shock. Not only did the coronavirus bear market remind investors that big downturns could happen, but it also came at a time when many investors hadn’t rebalanced their portfolios for a long time. As a result, many people’s stock allocations had risen above their past levels, leaving investors even more vulnerable to the stock market downturn.

    Add to that the fact that yields on bonds and other fixed-income investments have fallen to such low levels that the income they pay is insufficient for most investors’ needs. That pushed people into dividend stocks, boosting overall allocations to the stock market and further adding to risk.

    Avoiding the kneejerk reaction

    Many people realized only after the fact that they were uncomfortably overexposed to stocks in their investment portfolios. The worst possible way to respond would have been to sell at the lows. With markets down as much as 30% between mid-February and March, selling out would have meant taking huge losses. Moreover, you would’ve missed out on the nearly 40% gain in some stock market indexes since those lows, repeating a mistake that millions of investors have made in past crashes and bear markets.

    If you successfully held your ground and stuck with your strategy, you’ve probably seen a nice recovery in your portfolio. But that doesn’t mean that you should forget about your concerns regarding your risk tolerance. If you now know that you’re not inclined to deal with a drop of the magnitude we saw in early 2020, then you should adjust your investing strategy to be more conservative. Moreover, you can make those adjustments now, because reducing your stock portfolio won’t result in anywhere near the losses that you would’ve locked in just a couple months ago.

    2 ways to get your portfolio in line

    Investors have a couple of things they can do to adjust their portfolios to reflect their new risk tolerance. For some, it’ll be enough simply to rebalance your investments, getting your allocations to stocks, bonds, and other asset classes back in line with their long-term targets. Even though many stocks haven’t fully recovered their losses from the bear market, you might still find yourself needing to reduce your stock positions to rebalance effectively if it’s been a few years since you last did so.

    The more extreme move is to reduce your target stock allocation. That will necessarily involve making sales and exchanges of various investments, with the usual tax and cash flow consequences. For many, the peace of mind you can get from reducing the future volatility of your overall portfolio is worth the losses you’ll lock in — especially since those losses are probably much smaller than they were back in March or April.

    Don’t wait

    Stocks can do anything in the short run. Waiting to take action could let your portfolio recover further, but it could also leave you vulnerable to another leg lower if it comes.

    If you now realize your risk tolerance for stocks is lower than you thought it was, now’s the best time to adjust your portfolio to reflect your new needs. That way, you’ll be better prepared to deal with whatever comes next — and more likely to avoid mistakes that could cause long-term damage to your finances.

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    NEW! 5 Cheap Stocks With Massive Upside Potential

    Our experts at The Motley Fool have just released a FREE report detailing 5 shares you can buy now to take advantage of the much cheaper share prices on offer.

    One is a diversified conglomerate trading over 30% off it’s all-time high, all while offering a fully franked dividend yield of over 3%…

    Another is a former stock market darling that is one of Australia’s most popular and iconic businesses. Trading at a significant discount to its 52-week high, not only does this stock offer massive upside potential, but it also trades on an attractive fully franked dividend yield of almost 4%.

    Plus, this free report highlights 3 more cheap bets that could position you to profit in 2020 and beyond.

    Simply click here to scoop up your FREE copy and discover the names of all 5 cheap shares.

    But you will have to hurry because the cheap share prices on offer today might not last for long.

    As of 2/6/2020

    More reading

    Motley Fool contributor Dan Caplinger has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post If you need to protect your portfolio, do this now appeared first on Motley Fool Australia.

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    from Motley Fool Australia https://ift.tt/2YdC8x3

  • Musgrave Minerals share price jumps 40% after revealing bonanza gold results

    stacks of gold coins growing higher

    The Musgrave Minerals Ltd (ASX: MGV) share price is starting the trading week off with a bang after the small-cap ASX miner revealed bonanza grades in near surface drilling.

    Musgrave Minerals is an active Australian gold and base metals explorer. Its cornerstone project is the Cue Gold Project in the Murchison Province of Western Australia. The company also has a big footprint in the Musgrave Province, one of the least explored exploration frontiers in the country.

    For a bit of background, the Cue Gold Project hosts total resources of 6.45 million tonnes at 3.0 grams per tonne (g/t) gold for 613,000 ounces. This includes the Break of Day deposit (868,000 tonnes at 7.2 g/t gold for 199,000 ounces of contained gold) and the Lena deposit (4.3 million tonnes at 2.3 g/t gold for 325,000 ounces of contained gold).

    Why the Musgrave Minerals share price is surging

    This morning, Musgrave reported assay results for a further 7 reverse circulation (RC) drill holes from the current program at the new Starlight gold discovery.

    This follows the announcement of assay results for the first 12 RC drill holes last week which sent the Musgrave share price flying.

    Significant intercepts from today’s announcement include:

    • 42 metres at 77.3 g/t gold from 30 metres, including:
      • 18 metres at 179.4 g/t gold from 30 metres
    • 61 metres at 12.7 g/t gold from 76 metres, including:
      • 6 metres at 44.6 g/t gold from 76 metres
      • 21 metres at 23.6 g/t gold from 106 metres
    • 22 metres at 21.0 g/t gold 2 metres, including:
      • 9 metres at 49.2 g/t gold from 8 metres
    • 9 metres at 16.5 g/t gold from 225 metres, including:
      • 3 metres 47.6 g/t gold from 225 metres
    • 4 metres at 48.2 g/t gold from 85 metres
    • 2 metres at 37.7 g/t gold from 74 metres

    The Starlight link-lode is located at the Break of Day deposit within the Cue Gold Project. The intersections in all drill holes sit outside, but in close proximity to, the current resource at Break of Day.

    The drilling is focused on infilling and extending the new high-grade lode where mineralisation has been intersected over a strike of more than 115 metres.

    Commenting on the results, managing director Rob Waugh said:

    “These are amazing gold grades to see in near surface drilling. Our deepest holes to date are still in high-grade mineralisation at 200 vertical metres where Starlight remains open down dip. The bonanza grades near surface will have a significant positive impact on future development at Break of Day.”

    The current reverse circulation drilling program at Break of Day is now approximately 80% complete and consists of more than 36 holes for around 7,000 metres.

    Assays have been received for 19 holes to date, with further assays expected within 2 weeks.

    In addition, a diamond drilling program at Starlight to test depth extensions to the Starlight mineralisation is due to commence this week.

    After flying 45.83% at the open, the Musgrave Minerals share price is currently sitting 39.58% higher at 33.5 cents per share. This takes its market capitalisation at the time of writing to around $155 million.

    NEW. The Motley Fool AU Releases Five Cheap and Good Stocks to Buy for 2020 and beyond!

    Our experts here at The Motley Fool Australia have just released a fantastic report, detailing 5 dirt cheap shares that you can buy in 2020.

    One stock is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…

    Another is a diversified conglomerate trading over 40% off its high, all while offering a fully franked dividend yield over 3%…

    Plus 3 more cheap bets that could position you to profit over the next 12 months!

    See for yourself now. Simply click here or the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.

    CLICK HERE FOR YOUR FREE REPORT!

    More reading

    Motley Fool contributor Cathryn Goh has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Musgrave Minerals share price jumps 40% after revealing bonanza gold results appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/37hapQi

  • Where to invest $20,000 into ASX shares immediately

    Money

    At the weekend I looked at how investments of $20,000 in a number of ASX shares fared over the last 10 years.

    Given the success of these investments, this morning I thought I would look at a few shares which I feel investors ought to consider investing $20,000 into today for the next decade.

    Here why I think these three ASX shares could provide strong returns for investors:

    Altium Limited (ASX: ALU)

    I think this electronic design software platform provider could be a great place to invest $20,000 with a long term view. This is due to Altium’s exposure to the Internet of Things (IoT) boom. This rapidly growing market should drive strong demand for its offering in the future as the majority of these devices require software like Altium Designer during the design process. Management appears confident in its outlook and is aiming for 100,000 subscriptions by FY 2025. This compares to the 50,000 subscriptions it is targeting this year. Combined with its other growing businesses, such as the Octopart search engine, I believe the future is bright for Altium.

    Pushpay Holdings Group Ltd (ASX: PPH)

    Another company which I think has a very bright future is Pushpay. It is a growing donor management platform provider for the faith and not-for-profit sectors. Pushpay has been growing at a rapid rate over the last few years thanks to the increasing adoption of its platform by churches in the United States. The good news is that management expects its strong growth to continue in FY 2021. It recently revealed that it expects to double its operating earnings in FY 2021. But it doesn’t expect its growth to stop there. The company is aiming to capture 50% of the medium to large church market in the future. This is a US$1 billion revenue opportunity and many multiples of its current revenue.

    Ramsay Health Care Limited (ASX: RHC)

    A third ASX share to consider investing $2o,000 into is Ramsay Health Care. I think the leading private healthcare company would be a great long term option due to the quality of its global business and its positive long term outlook. The latter is thanks to the ageing populations tailwind, which is expected to drive very strong demand for healthcare services over the next couple of decades. And while trading conditions are tough right now, I believe it is worth dealing with the short term pain for the potential long term gains.

    And if you have some funds leftover, these five recommendations below look like potential market beaters…

    5 ASX stocks under $5

    One trick to potentially generating life-changing wealth from the stock market is to buy early-stage growth companies when their share prices still look dirt cheap.

    Motley Fool’s resident tech stock expert Dr. Anirban Mahanti has identified 5 stocks he thinks are screaming buys. And you can buy them now for less than $5 a share!

    *  Extreme Opportunities returns as of June 5th 2020

    More reading

    James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Altium and PUSHPAY FPO NZX. The Motley Fool Australia has recommended PUSHPAY FPO NZX and Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Where to invest $20,000 into ASX shares immediately appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2MIwSvS

  • Is the Webjet share price a cheap buy today?

    plane flying across share markey graph, asx 200 travel shares, qantas share price

    The Webjet Limited (ASX: WEB) share price rocketed 8.45% last week and has opened higher today. But will the Aussie travel share continue to head higher in 2020?

    Is the Webjet share price a cheap buy?

    It was a good week for the S&P/ASX 200 Index (ASX: XJO) which climbed 4.22% higher to 5,998.70 points.

    Webjet was just one of many ASX 200 shares to climb higher as investors piled into shares. 

    There’s growing optimism about ASX travel shares like Webjet as coronavirus restrictions continue to ease. 

    It looks like there will still be some tough times ahead. However, many Aussies have been cooped up and are looking towards their next getaway.

    Whether that is domestically or overseas, it’s good news for the Webjet share price. The ASX travel share is still down nearly 50% in 2020 which is a healthy discount. In contrast, the S&P/ASX 200 Index has fallen just 7.67% lower at the time of writing.

    That could mean the Webjet share price is a bargain. However, it’s far from certain that we’ll see a quick share price recovery in 2020.

    While airlines are starting to ramp up their flight numbers, capacity is still well down on where we started the year. 

    There’s also another issue: demand. Just because there’s the ability to travel, many Aussies have fallen on hard times during the pandemic. 

    There could be a couple of ways this plays out for the Webjet share price. There could well be a surge in demand as people take advantage of the ability to travel.

    On the other hand, we could see more Aussies saving their cash and being conservative. There could also be some skepticism about travel safety despite more options being made available.

    All these unknowns say to me that the Webjet share price could be cheap but it’s a speculative play as to where the travel industry is headed.

    Foolish takeaway

    The Webjet share price surged higher last week and has some strong momentum behind it in this week’s trade.

    However, I feel the ASX travel share is far from a certain buy and I think I’ll wait until I see August earnings figures before jumping in.

    Here are a few more cheap ASX shares to buy in the month ahead.

    NEW! 5 Cheap Stocks With Massive Upside Potential

    Our experts at The Motley Fool have just released a FREE report detailing 5 shares you can buy now to take advantage of the much cheaper share prices on offer.

    One is a diversified conglomerate trading over 30% off it’s all-time high, all while offering a fully franked dividend yield of over 3%…

    Another is a former stock market darling that is one of Australia’s most popular and iconic businesses. Trading at a significant discount to its 52-week high, not only does this stock offer massive upside potential, but it also trades on an attractive fully franked dividend yield of almost 4%.

    Plus, this free report highlights 3 more cheap bets that could position you to profit in 2020 and beyond.

    Simply click here to scoop up your FREE copy and discover the names of all 5 cheap shares.

    But you will have to hurry because the cheap share prices on offer today might not last for long.

    As of 2/6/2020

    More reading

    Motley Fool contributor Ken Hall has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Webjet Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Is the Webjet share price a cheap buy today? appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2XMW62N

  • G8 Education share price jumps higher despite the government ending its free childcare scheme

    child care shares

    The G8 Education Ltd (ASX: GEM) share price has been a strong performer this morning and is trading notably higher.

    At the time of writing the childcare centre operator’s shares are up over 6% to $1.10. This compares favourably to an impressive 3.1% gain by the S&P/ASX 200 Index (ASX: XJO).

    Why is the G8 Education share price outperforming?

    The catalyst for this outperformance has been an announcement this morning in response to one by the Federal Government on Monday.

    The latter announcement revealed that the government intends to end its free childcare scheme in July and reintroduce the Child Care Subsidy (CSS). It will also bring to an end its JobKeeper payment for workers in the sector next month.

    While you might imagine this to be a negative, it won’t actually be for G8 Education. This is because there will be a three-month transition period that aims to support the early learning sector during a period of reduced occupancy levels.

    According to G8’s announcement, early learning and care providers, including G8, will receive a transition payment equal to 25% of each centre’s fee levels prior to the impact of the pandemic. This is based on fees received in the fortnight prior to 1 March 2020.

    Management revealed that this equates to approximately half of the amount received under the relief package, but will be paid in addition to the normal CCS and co-parent payments. Though, this transition payment is conditional on early learning and care providers maintaining average gross employment levels during this period.

    Another positive is that the Federal Government will ease the activity test requirements that determine a family’s access to the CCS. Management expects this to make early learning more accessible and affordable to certain families. This includes those whose employment has been impacted due to the pandemic.

    G8 Chief Executive Officer and Managing Director, Gary Carroll, commented: “The transitional arrangements announced today are welcome as they provide operators with increased flexibility to support families as the economy recovers. We look forward to continuing to engage with government and other stakeholders to ensure the right settings are in place to support our families and team members.”

    What will be the financial impact?

    Management notes that the revised government support packages are structured in a way that means G8 expects to be in no worse a position relative to the prior support measures.

    This is even if occupancy levels become more subdued than they currently are.

    Occupancy levels update.

    The company also revealed that its booked occupancy rate is currently ~65%. However, physical attendance is approximately 52%, as some parents continue to choose to keep their children at home despite having a booking at a centre.

    During May, physical attendance improved ~20 percentage points off the April low of ~30%.

    Not sure about G8 right now? Then check out the highly recommended shares below…

    3 “Double Down” Stocks To Ride The Bull Market

    Motley Fool resident tech stock expert Dr. Anirban Mahanti has stumbled upon three under-the-radar stock picks he believes could be some of the greatest discoveries of his investing career.

    He’s so confident in their future prospects that he has issued “double down” buy alerts on each of these three stocks to members of his Motley Fool Extreme Opportunities stock picking service.

    *Extreme Opportunities returns as of June 5th 2020

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post G8 Education share price jumps higher despite the government ending its free childcare scheme appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3h9JfiA

  • After Novavax Inks DoD Contract, Is Operation Warp Speed Ahead? Top Analyst Weighs In

    After Novavax Inks DoD Contract, Is Operation Warp Speed Ahead? Top Analyst Weighs InAnother day, another stride forward in the race to develop a COVID-19 vaccine.On June 4, Novavax (NVAX) revealed it will receive $60 million from the U.S. Department of Defense (DoD) to further the advancement of its experimental vaccine candidate, NVX-CoV2373, in the U.S., through JPEOCBRND-EB (Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense Enabling Biotechnologies).As per the terms of the agreement, NVAX will work with multiple biologics contract development manufacturing organizations (CDMO) based in the U.S. to increase the scale of antigen and Matrix-M adjuvant production, which are both components of the vaccine. The end goal is to produce 10 million doses for the DoD in 2020, which will then be used in either a Phase 2/3 trial or under an Emergency Use Authorization (EUA).Weighing in on this development for B.Riley FBR, five-star analyst Mayank Mamtani tells investors he’s “encouraged” by the grant, arguing that the U.S. military is a “key population subset of national security importance.”However, Mamtani believes the implications go even further. “We believe this development is in sharp contrast to 3/6 media report speculating NVAX being excluded from the list of five finalists chosen by the Trump administration via Operation Warp Speed (OWS). In fact, this development further strengthens our conviction in a sizeable funding to be secured from U.S. BARDA which has ~$4 billion leftover from the original $6.5 billion allocation under the CARES Act for COVID-19 vaccine development and manufacturing; AstraZeneca/Univ. of Oxford, Moderna, J&J and Merck have been the beneficiaries to date, which might have been potential alternatives considered for this DoD contract,” he explained.While some investors might see the need for U.S.-based CDMO to deliver on this contract as a cause for concern, Mamtani points out that NVAX has already secured capacity. The $388 million grant from the Coalition for Epidemic Preparedness Innovations (CEPI) should be enough to support it through the Phase 2b trial. The non-dilutive funding will instead go towards the Phase 3 NVX-CoV2373 clinical efficacy (outcomes) study and large-scale manufacturing activities. The analyst added, “Here, we think U.S. BARDA could likely commit to secure access for '2373 to be expanded in high-risk, frontline workers and/or elderly in an effort to allow for approval of a tried and tested recombinant protein-based vaccine.”With earlier availability of the candidate for stockpiling now likely, the deal is sealed for Mamtani. The analyst rates NVAX a Buy along with a $74 price target. (To watch Mamtani’s track record, click here)      In general, other analysts echo Mamtani’s sentiment. 5 Buys and 1 Hold add up to a Strong Buy consensus rating. Given the $50.83 average price target, the upside potential comes in at 13.5%. (See Novavax stock analysis on TipRanks)To find good ideas for stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.

    from Yahoo Finance https://ift.tt/2XKBMiw